Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
16.09
+0.49 (3.14%)
At close: Nov 22, 2024, 4:00 PM
16.25
+0.16 (0.99%)
After-hours: Nov 22, 2024, 5:19 PM EST
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.37 billion as of November 22, 2024. Its market cap has increased by 39.87% in one year.
Market Cap
1.37B
Enterprise Value
967.86M
1-Year Change
39.87%
Ranking
Category
Stock Price
$16.09
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.37B, an increase of 558.39%. That is a compound annual growth rate of 24.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 1.33B | -11.52% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 1.35B |
| Day One Biopharmaceuticals | 1.35B |
| Indivior | 1.34B |
| Ocular Therapeutix | 1.34B |
| Evolent Health | 1.33B |
| STAAR Surgical Company | 1.31B |
| Arcus Biosciences | 1.31B |
| AdaptHealth | 1.30B |